← Back to patent-cliff list
LH-8
Tier C — Watch / tradeLH-8
Legacy Healthcare Sa
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Updating
Indications (approved)：Alopecia areata
Regional status
US
-
EU
Phase III
2018-02-01
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of LH-8?
Approved indications include: Alopecia areata.
When does the LH-8 patent expire?
No public expiry year is available for LH-8 yet; this page updates once verified.
How do I get a quote for LH-8 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-09